Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Gottardo Lab is a Research Lab within the Computational Biology department at the Fred Hutchinson Cancer Research Center. We develop statistical methods and computational tools for managing and analyzing high-throughput biological data including single-cell RNA-seq, flow-cytometry, CyTOF and CITE-seq, to name a few. We then utilize these tools, in collaboration with immunologists and clinicians, to analyze high-dimensional data from pre-clinical and clinical trials in an effort to accelerate the development of new cancer immunotherapies and vaccines. Our lab participates in large collaborative efforts funded by the NIH, Gates Foundation and the CZI including the Human Immunology Project Consortium, the Human Cell Atlas, the Cancer Immunotherapy Trial Network and the Collaboration for AIDS Vaccine Discovery.
As a lab, we value inclusion and a diversity of backgrounds and perspectives to inform our work. We believe in supporting each other through mentorship and providing resources for professional development. Given these values, we strive to make our recruitment and promotion processes fair and transparent. Therefore, we strongly encourage all individuals with an interest in the position to apply. To learn more about our lab visit rglab.org .
Develop statistical and computational methods for analyzing and integrating high dimensional single-cell data generated by cutting-edge technologies including single-cell RNA-seq, CITE-seq, flow cytometry and CyTOF
Work with immunologists and clinicians to apply these tools in the context of cancer immunotherapy and vaccine development.
Recent PhD degree in statistics/biostatistics, computer science, or other fields with strong quantitative training or experience
Strong programming skills in C/C++, R or similar languages
Ability to communicate effectively and work in a team-based setting
Background in Biology
Previous experience with genomics or immunological data analyses
Experience with good software development practices (e.g. design, unit tests, documentation, code review) for reproducible science
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.